×
Customize
?
Start
Cancer Types
Quick Links
Award Programs
Cure Media Group, LLC.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873
Copyright © 2019
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873
Copyright © 2019
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.
Kidney Cancer
Katie Kosko
From a Hallmark Channel actor revealing a kidney cancer diagnosis to a donor match first-time meeting 20 years later, here’s what is making headlines in the cancer space this week.
Katie Kosko
Patients with renal cell carcinoma who were treated with a targeted therapy lived three months longer than people who received older treatments.
Jessica Skarzynski
One expert discusses the “extremely interesting and extremely dynamic” field of renal cell carcinoma, and how recent research and FDA actions could offer hope for patients and their doctors.
Kristie L. Kahl
In assessing the quality of family cancer history entered into electronic health records, researchers found that such reporting was suboptimal – highlighting the need to optimize online collection with a provider-free approach.
The importance of support networks and a multidisciplinary team when managing advanced-stage renal cancer.
A discussion regarding the significance of dose modification to mitigate toxicity burden.
Steven Gallant, a stage 4 renal cell cancer survivor, discusses how he managed the toxicities of cabozantinib frontline therapy.
A discussion regarding the frontline treatment options for aggressive renal cell cancer, and the factors considered in choosing the appropriate therapy.
Practical advice for patients during the diagnostic process of renal cell cancer.
Karl J. D’Silva, M.D., and Steven Gallant discuss the process of being diagnosed with stage 4 renal cell cancer.